Phone-delivered healthy behavior programs to prevent insomnia in people with HIV with chronic pain
Official title: Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain
Run by Washington University School of Medicine · NCT07270406 · Data updated 2026-11-12
This test compares brief phone-delivered behavioral insomnia treatment versus brief phone-delivered mindfulness training to see if they reduce insomnia, ease chronic pain, and slow biological aging in adults with HIV who have ongoing pain.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 25 Years to 65 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Washington University School of Medicine Academic / other |
| Locations | 1 site (St Louis, Missouri) |
| Status | Recruiting |
| Started | February 16, 2026 |
| Main results expected | September 16, 2029 |
| Study ends | April 30, 2030 |
| Registry record updated | July 7, 2026 |
| Trial ID | NCT07270406 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people with HIV aged 25–65 who are on stable antiretroviral therapy, have chronic pain rated ≥3/10, and meet insomnia criteria (Insomnia Severity Index ≥15 and DSM-5 insomnia for at least three months).
✕Probably not a fit
People without clinically significant insomnia or chronic pain, those not receiving care at the WashU Infectious Disease Clinic, or those with exclusionary conditions such as recent stroke, active cancer treatment, or heart disease are unlikely to be eligible or to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with HIV aged 25–65 who are on stable antiretroviral therapy and report chronic pain and clinically significant insomnia are enrolled at Washington University School of Medicine. Participants receive either brief behavioral treatment for insomnia (BBTI) or brief mindfulness training (BMT), both delivered by phone, with scheduled sessions and follow-up assessments. The study measures changes in insomnia severity, pain intensity, and markers of biological aging collected through clinical assessments and blood-based tests. The approach emphasizes low-burden, phone-delivered interventions tailored to a clinic-based HIV population.
Why it matters
Potential benefit: If successful, the interventions could improve sleep, reduce chronic pain, and potentially slow biological aging for people with HIV.
How similar studies have gone: Previous research shows that brief behavioral insomnia treatments and mindfulness can improve sleep and reduce pain, although phone-delivered programs and effects on biological aging are less well-established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria Each subject must meet all of the following criteria and be confirmed with electronic medical records: 1. Confirmed HIV diagnosis and currently a patient in the WashU Infectious Disease Clinic 2. Age 25-65 years 3. All people with HIV must be currently receiving stable antiretroviral therapy 4. People with HIV with insomnia must report Insomnia Severity Index \>/= 15 at initial screening and meet DSM-5 diagnostic criteria for insomnia including sleep difficulty that occurs at least 3 times per week and has been a problem for at least 3 consecutive months 5. People with HIV must also report the presence of chronic pain on the Brief Chronic Pain Screening Questionnaire and rate their chronic pain as \>/= 3 on a 0-10 scale of intensity. Exclusion Criteria Subjects will not be enrolled if any of the following criteria exist and confirmed with electronic medical records: 1. History of stroke in past 12 months 2. Active cancer with treatment 3. Heart disease 4. Uncontrolled hypertension 5. Epilepsy 6. Active pregnancy 7. Reynaud's disease 8. Traumatic injury or surgical procedure within the last 12 months 9. Acute infection as suggested by thermometry temperature \>100.4 10. Serious psychiatric disorder (bipolar disorder, psychotic disorder) 11. Active suicidal ideation 12. Evidence for severe obstructive sleep apnea (AHI \>30/hr) according to Home Sleep Monitoring or presence of another sleep disorder other than insomnia (i.e., not insomnia) as indicated by SCISD-R
Where it's running
-
Washington University School of Medicine
St Louis, Missouri, United States Recruiting
Study contacts
- Principal investigator: Burel Goodin, PhD — WashU Medicine
- Study coordinator: Dyan White-Gilliam, BS
- Email: dyanw@wustl.edu
- Phone: 314-747-4317
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Transcranial Direct Current Stimulation for Long COVID with Headaches and Chronic Pain
This study tests whether applying mild brain stimulation (tDCS) can help people with long COVID who have headaches, migraines, and ongoing pain.
-
SleepCogni for children with chronic insomnia
A handheld SleepCogni device is tested to see if it helps kids aged 6–16 with chronic insomnia sleep better.
-
Cognitive Rehabilitation of Everyday Goals With GMT: How Different Ways of Delivery Work
This study tests Goal Management Training to see if a Swedish version helps adults with acquired brain injury or chronic pain improve practical goal-directed thinking and daily functioning.
-
One-time Pain Reprocessing Therapy session for chronic pain at The Ottawa Hospital
A single four-hour session of Pain Reprocessing Therapy is being tested to see if it can help adults with chronic pain feel better and have less pain.
-
Meaning-Based Psychotherapy for Adults with Chronic Pain
This trial tests whether Meaning-Based Psychotherapy helps adults with chronic pain feel more purposeful, feel less depressed, and have a better quality of life compared with optimized usual care therapy.
-
Music therapy after stroke
This trial tests whether adding music therapy to standard care helps stroke patients sleep better and feel less anxious or depressed while in the hospital.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.